Nevertheless, a limitation of the present study is that we did not examine additional pathways potentially involved in the induction of insulin resistance by Sfrp5, such as activation of the proteasome [17] or the mammalian target of rapamycin complex 1 signaling cascade [21]. The gene discussed is SFRP5; the disease is Insulin resistance.